You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR PULMICORT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for PULMICORT

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	CAMP Steering Committee	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00005880 ↗	Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia	Completed	National Cancer Institute (NCI)	Phase 2	2000-07-01	RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of budesonide may be an effective way to prevent bronchial dysplasia. PURPOSE: Randomized double-blinded phase II trial to determine the effectiveness of budesonide in treating former or current smokers who have bronchial dysplasia.
NCT00005880 ↗	Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia	Completed	British Columbia Cancer Agency	Phase 2	2000-07-01	RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of budesonide may be an effective way to prevent bronchial dysplasia. PURPOSE: Randomized double-blinded phase II trial to determine the effectiveness of budesonide in treating former or current smokers who have bronchial dysplasia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for PULMICORT

Condition Name

Chart
Table

Condition Name for PULMICORT
Intervention	Trials
Asthma	42
Chronic Obstructive Pulmonary Disease	4
Respiratory Distress Syndrome	4
Bronchopulmonary Dysplasia	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for PULMICORT
Intervention	Trials
Asthma	45
Lung Diseases	9
Pulmonary Disease, Chronic Obstructive	6
Respiratory Distress Syndrome, Newborn	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PULMICORT

Trials by Country

Map
Table

Trials by Country for PULMICORT
Location	Trials
United States	49
Canada	23
China	21
Japan	21
United Kingdom	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for PULMICORT
Location	Trials
California	5
North Carolina	5
New York	4
Arizona	4
Pennsylvania	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PULMICORT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for PULMICORT
Clinical Trial Phase	Trials
Phase 4	29
Phase 3	20
Phase 2/Phase 3	3
[disabled in preview]	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for PULMICORT
Clinical Trial Phase	Trials
Completed	51
Unknown status	12
Withdrawn	5
[disabled in preview]	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PULMICORT

Sponsor Name

Chart
Table

Sponsor Name for PULMICORT
Sponsor	Trials
AstraZeneca	28
St. Paul's Hospital, Canada	4
National Cancer Institute (NCI)	3
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for PULMICORT
Sponsor	Trials
Other	100
Industry	41
NIH	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.